Professor Creswell Eastman AO is a world-renowned endocrinologist with a primary interest in Iodine Deficiency Disorders. He is the Clinical Professor of Medicine at the University of Sydney School of Medicine and Consultant Emeritus to Westmead Hospital.
Professor Eastman recently spoke to Australian Health Journal about iodine deficiency in pregnancy preparation and the mother’s health during pregnancy. May is the time of the year for the Australian Thyroid Foundation’s (ATF) Thyroid Awareness Month and Professor Eastman spoke about why iodine deficiency has become an even greater risk in Australians in recent years. He stresses the importance of public health literacy and health care professionals (HCPs) having a better understanding of the disorders associated with iodine deficiency.
Recent research from The Lancet – March 2022 emphasises the consequences and risks of an inadequate amount of thyroid hormone at conception, during pregnancy and whilst breastfeeding.
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
‘Unnecessary risks to a pregnancy and the mother’s health during pregnancy and ongoing is something that can be avoided and prevented. Raising awareness and ensuring thyroid tests are ordered by GP’s, when couples are planning a family and when the pregnancy is confirmed are both essential.
-
Care workforce challenges
In a wide ranging report looking at the carer needs across Australia, PwC Australia published Reimagine Care Workforce Solutions in October 2022.
Australian Health Journal spoke with Kerryn Dillon, Director Ageing and Reablement and Health Workforce at PwC Australia about the community care sectors of aged care, disability care and childcare the report covers.
-
New research papers show productivity gains and gaps
Commissioner Catherine De Fontenay talks about the Productivity Commission’s new approach to analysing health productivity, shifting the perspective from the unit measurement of individuals using the health system to the actual improvement of health. This has shown Australia’s health treatment productivity is improving, but identifies gaps in preventative health measures and duplication, where digital technology needs to be more effectively used.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
